Industries of the future are built on biology
Biotechnology will produce therapies and cures for today’s deadliest diseases, vaccines for the next pandemic, alternative sources of food and energy, and materials for a more sustainable future.
Enabling real-time insights into cellular biology to accelerate therapeutic research, development, and manufacturing with an AI-driven cloud platform for metabolomics.
Biotechnology will produce therapies and cures for today’s deadliest diseases, vaccines for the next pandemic, alternative sources of food and energy, and materials for a more sustainable future.
At the center of the bio-economy is the cell. Bioengineers program the molecular machinery of cells to produce valuable antibodies, enzymes, proteins, industrial chemicals, and numerous other biomolecular products.
While our ability to sequence DNA and RNA has improved dramatically over the last decade, our ability to characterize the small molecules that power cellular processes — collectively, the metabolome — remains limited.
Quick and reliable access to this window into the dynamic state of a cell is essential to engineering biology, and yet the traditional tools and methods of metabolomics are unsuited for the task. To meet the challenges of today and tomorrow, we need to fundamentally rethink the technologies we use.
We use artificial intelligence to decode mass spectrometric signals into actionable biological data.
Our digital metabolomics platform enables optimized production of numerous biological products manufactured in the cell.
Enzymes
Specialty Chemicals
Antibodies
Viral Vectors
Vaccines
Peptides
Therapeutic Proteins